BCL2 and acute myeloid leukemia: In particular, IV and VI sub-fractions specifically activated, in both AML cell lines, the intrinsic apoptotic pathway as evidenced by the decrease of the apoptosis inhibitor protein Bcl2 (Figure 5) [57].